Protocol for in vivo CRISPR screening using selective CRISPR antigen removal lentiviral vectors
使用选择性 CRISPR 抗原去除慢病毒载体进行体内 CRISPR 筛选的方案
阅读:5
作者:Sarah Kate Lane-Reticker, Emily A Kessler, Audrey J Muscato, Sarah Y Kim, John G Doench, Kathleen B Yates, Robert T Manguso, Juan Dubrot
| 期刊: | STAR Protocols | 影响因子: | 1.300 |
| 时间: | 2023 | 起止号: | 2023 Mar 17;4(1):102082. |
| doi: | 10.1016/j.xpro.2023.102082 | 研究方向: | 微生物学 |
Abstract
Recognition of Cas9 and other proteins encoded in delivery vectors has limited CRISPR technology in vivo. Here, we present a protocol for genome engineering using selective CRISPR antigen removal (SCAR) lentiviral vectors in Renca mouse model. This protocol describes how to conduct an in vivo genetic screen with a sgRNA library and SCAR vectors that can be applied to different cell lines and contexts. For complete details on the use and execution of this protocol, please refer to Dubrot et al. (2021).1.
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。